Over the years, Danes Camp Research and Training Academy has successfully delivered a variety of research studies. These studies have focused on areas such as long-term health conditions, new treatment approaches, and innovative models of care. By working closely with patients, healthcare professionals, and research bodies, we have been able to contribute valuable evidence that has helped shape clinical practice and improve patient outcomes. Our previous research highlights our ongoing commitment to supporting high-quality studies that bring real benefits to our community and beyond.
At Danes Camp Research and Training Academy, we are proud to have contributed to the GENVASC study, a large national research programme focused on improving the prevention of cardiovascular disease (CVD).
Dr. Zafar served as the Principal Investigator for Northamptonshire, leading the local delivery of this important study. The aim of GENVASC was to evaluate the clinical effectiveness of the NHS Health Check (NHSHC) programme in identifying and reducing cardiovascular disease risk in the community. By assessing how health checks can be enhanced, the study sought to provide valuable evidence to improve early detection, prevention, and management of CVD across the NHS.
Through our local efforts, we successfully recruited 281 patients to take part in the study. Their contribution has helped generate insights that will support better cardiovascular health outcomes nationally.
The GENVASC study reflects our commitment to research that directly benefits patients by shaping the way healthcare is delivered, ensuring that services are both effective and evidence-based.
The PANORAMIC trial was a landmark national study designed to evaluate potential treatments for COVID-19 in the community. Under the leadership of Dr. Zafar, Principal Investigator for Northamptonshire, our site played an important role in contributing to this vital research.
The trial investigated whether adding molnupiravir, an oral antiviral medication, to usual care could help reduce COVID-19-related hospitalisations and deaths among patients at higher risk of severe illness. This research provided essential evidence to guide treatment decisions during the pandemic and has had a significant impact on shaping how COVID-19 is managed in community settings.
At our site, we successfully recruited 152 patients to the study. Their participation and contribution were critical in generating the real-world evidence needed to inform national and international healthcare strategies during one of the most challenging times in recent history.
The PANORAMIC trial highlights our ongoing commitment to being at the forefront of research that directly benefits patients and supports public health.
The PREP in Pharmacy (UNITY) study explored the barriers and facilitators faced by both pharmacists and the general public regarding the routine provision of PREP (pre-exposure prophylaxis) in community pharmacies across the UK. PREP is an important medication that helps prevent HIV, and understanding how it can be more widely and effectively provided is vital for improving access and reducing health inequalities.
As part of this national study, our teams at Rillwood Medical Centre (RWMC) and Danes Camp Medical Centre (DCMC) played a key role in supporting recruitment and engagement. Together, we successfully recruited 219 participants across both sites. Their input has contributed to valuable evidence on how PREP could be more routinely integrated into community pharmacy settings, making it more accessible to those who need it most.
The UNITY study reflects our commitment to supporting inclusive, community-focused research that addresses real-world healthcare needs and helps shape future NHS services.
The DVA study focused on the role of primary care in identifying and addressing domestic violence and abuse (DVA) within the community setting. Domestic violence and abuse can have a profound impact on the health and wellbeing of individuals and families, and primary care services are often a first point of contact where signs may be recognised, and support offered.
Our teams at Rillwood Medical Centre (RWMC) and Danes Camp Medical Centre (DCMC) were proud to contribute to this important research. Together, we successfully recruited 321 participants across both sites. Their involvement has provided valuable evidence on how primary care can play a stronger role in supporting patients affected by domestic violence and abuse and ensuring they receive the help they need.
This study demonstrates our commitment to research that not only improves clinical outcomes but also addresses critical social issues that affect health and wellbeing in our communities.